Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register

被引:36
作者
Nilsson, Peter M. [1 ]
Cederholm, Jan [3 ]
Eeg-Olofsson, Katarina [4 ]
Eliasson, Bjorn [4 ]
Zethelius, Bjorn [2 ]
Fagard, Robert [5 ]
Gudbjornsdottir, Soffia [4 ]
机构
[1] Lund Univ, Univ Hosp, Dept Clin Sci, S-20502 Malmo, Sweden
[2] Uppsala Univ, Dept Publ Hlth & Caring Sci, Geriatr Sect, Uppsala, Sweden
[3] Uppsala Univ, Dept Publ Hlth & Caring Sci, Family Med & Clin Epidemiol Sect, Uppsala, Sweden
[4] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden
[5] Katholieke Univ Leuven, Univ Leuven, Fac Med, Hypertens & Cardiovasc Rehabil Unit, Louvain, Belgium
来源
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2009年 / 16卷 / 04期
关键词
cardiovascular diseases; diabetes; myocardial infarction; smoking; stroke; CORONARY-HEART-DISEASE; FOLLOW-UP; CIGARETTE-SMOKING; CESSATION; WOMEN; INTERVENTION; COHORT; TRIAL; MEN; GUIDELINES;
D O I
10.1097/HJR.0b013e32832ccc50
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background Few earlier studies have analysed smoking as a risk factor for myocardial infarction NO or stroke in type 2 diabetic patients. Design and methods A longitudinal study involved 13087 female and male patients with type 2 diabetes from the Swedish National Diabetes Register with no previous M I or stroke at baseline, aged 30-74 years, and with data available for all analysed variables, followed up for mean 5.7 years. Results Adjusted hazard ratios (HRs) for smoking and first-incident fatal/nonfatal MI, stroke and total mortality were 1.7 [95% confidence interval (CI): 1.4-2.0; P<0.001], 1.3 (95% CI: 1.1-1.6; P=0.006) and 1.8 (95% CI: 1.5-2.2; P<0.001), respectively, by Cox regression analysis, adjusted for age, sex, diabetes duration, hypoglycaemic treatment, haemoglobin A(1c), blood pressure, body mass index, microalbuminuria, antihypertensive and lipid-lowering drugs. Adjusted HR was higher for fatal MI, 2.1 (95% CI: 1.7-2.7; P<0.001), than for nonfatal MI, 1.4 (95% CI: 1.2-1.7; P<0.001). The highest HRs were observed in more frequently smoking (22%), middle-aged patients (age <60 years) for fatal/nonfatal MI, 2.3 (95% CI: 1.8-3.1; P<0.001) and for total mortality, 2.5 (95% CI: 1.6-3.8, P<0.001), whereas lower HRs were observed in older and less smoking patients. With predicted cessation of smoking in patients aged below 60 years, 24% (95% CI: 15-33%) of cases of fatal/nonfatal MI and 24% (11-37%) of cases of total mortality may have been prevented. Conclusion The risk for MI and total mortality associated with smoking is high in type 2 diabetes, especially in more frequently smoking, middle-aged patients, and was higher for MI than for stroke, and also higher for fatal than for nonfatal events. Smoking cessation would strongly affect risk reduction. Eur J Cardiovasc Prev Rehabil 16:506-512 (C) 2009 The European Society of Cardiology
引用
收藏
页码:506 / 512
页数:7
相关论文
共 36 条
[1]
Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus [J].
Al-Delaimy, WK ;
Manson, JE ;
Solomon, CG ;
Kawachi, I ;
Stampfer, MJ ;
Willett, WC ;
Hu, FB .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (03) :273-279
[2]
Cigarette smoking and risk of coronary heart disease incidence among middle-aged Japanese men and women: the JPHC Study Cohort I [J].
Baba, Shunroku ;
Iso, Hiroyasu ;
Mannami, Toshifumi ;
Sasaki, Satoshi ;
Okada, Katsutoshi ;
Konishi, Masamitsu ;
Tsugane, Shoichiro .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2006, 13 (02) :207-213
[3]
Intervention study for smoking cessation in diabetic patients -: A randomized controlled trial in both clinical and primary care settings [J].
Canga, N ;
De Irala, J ;
Vara, E ;
Duaso, MJ ;
Ferrer, A ;
Martínez-González, MA .
DIABETES CARE, 2000, 23 (10) :1455-1460
[4]
Risk Prediction of Cardiovascular Disease in Type 2 Diabetes [J].
Cederholm, Jan ;
Eeg-Olofsson, Katarina ;
Eliasson, Bjoern ;
Zethelius, Bjoern ;
Nilsson, Peter M. ;
Gudbjornsdottir, Soffia .
DIABETES CARE, 2008, 31 (10) :2038-2043
[5]
Dagenais GR, 2005, EUR J CARDIOV PREV R, V12, P75
[6]
Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients [J].
Eeg-Olofsson, K. ;
Cederholm, J. ;
Nilsson, P. M. ;
Zethelius, B. ;
Nunez, L. ;
Gudbjoernsdottir, S. ;
Eliasson, B. .
DIABETOLOGIA, 2009, 52 (01) :65-73
[7]
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials [J].
Eisenberg, Mark J. ;
Filion, Kristian B. ;
Yavin, Daniel ;
Belisle, Patrick ;
Mottillo, Salvatore ;
Joseph, Lawrence ;
Gervais, Andre ;
O'Loughlin, Jennifer ;
Paradis, Gilles ;
Rinfret, Stephane ;
Pilote, Louise .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2008, 179 (02) :135-144
[8]
The gap between guidelines and reality:: Type 2 diabetes in a national diabetes register 1996-2003 [J].
Eliasson, B ;
Cederholm, J ;
Nilsson, P ;
Gudbjörnsdóttir, S .
DIABETIC MEDICINE, 2005, 22 (10) :1420-1426
[9]
*EP CTR SWED NAT B, 2000, HLTH PEOPL DAT TABL
[10]
INSULIN RESISTANCE AND CIGARETTE-SMOKING [J].
FACCHINI, FS ;
HOLLENBECK, CB ;
JEPPESEN, J ;
CHEN, YDI ;
REAVEN, GM .
LANCET, 1992, 339 (8802) :1128-1130